ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

NCAB Approved NTP Transfer To NIEHS But Without Much Enthusiasm

May 30, 1980

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

Epstein Back With New Attack On “Establishment” In Congressional Record

November 6, 1987

Segmental Study Finally Published, Says Less Surgery as Good as More, Radiation Helped

March 22, 1985